MAPT and Alzheimer disease: The p-tau isoforms, p-tau threonine 181, p-tau threonine 217, and p-tau threonine 231, plasma levels strongly correlate with CSF values and are considered AD’s early mid stage (Braak 3–4) biomarkers and predictors of Aβ− to Aβ+ conversion in MCI patients [199].